
Starts 25 September 2027
25 to 26 September 2027
International Advanced SINUS DISSECTION Course
Lukang, Taiwan · In person
IRCAD Taiwan
- 2days
- In personevent
- $34,000cheapest ticket, as stated by www.ircadtaiwan.com
Lukang
Taiwan
About this conference
Details
Dates
25 to 26 September 2027Fees
Observer NT$34,000 (about USD 1,040 for reference); lectures and cadaver workshop NT$64,000 (about USD 2,000 for reference). Early bird discount deadline stated as 3 August 2026.
Venue
IRCAD Taiwan Laparoscopic Training Center, Lukang Township, Changhua County
Lukang, Taiwan
Interactive map. With the map focused, use the arrow keys to move it and the plus and minus keys to zoom. The address and a link to Google Maps are written beside it.
Around Lukang
Places, weather and events near the venue load as you scroll.
Before you book
- Cancellation policy
- Early bird purchases are non-refundable; refunds are 100% at 45 days or more before the course, 75% at 31-44 days, 50% at 15-30 days, and none within 14 days.
Explore more
Similar
- Physician specialties conferences in Asia in 2027, 88 conferences
- Physician specialties conferences in Asia in September 2027, 5 conferences
- Physician specialties conferences in 2027, 1,193 conferences
- Conferences in Asia in 2027, 370 conferences
- Physician specialties conferences in Asia, 136 conferences
- Physician specialties conferences in September 2027, 84 conferences
- Conferences in Asia in September 2027, 18 conferences
- Conferences in Taiwan in 2027, 14 conferences
Physician specialties
1 to 3 September 2027 · Bar Harbor, United States
1 to 6 September 2027 · Stanley, United States
1 to 3 September 2027 · Heidelberg, Germany
2 to 3 September 2027 · Lausanne, Switzerland
3 to 4 September 2027 · Galway, Ireland
3 to 4 September 2027 · Seoul, South Korea
Spotted something wrong?
Tell us which detail looks off and we will check it against the source. We read every report and reply to each one.
Do you run this event? Claim this listing to keep its details right. Claiming gives you editing rights and no mark of approval.